Medicare Enrolled
Dr. Ajay Kwatra, MD
Urology Physician · Conroe, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kwatra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kwatra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kwatra
Dr. Ajay Kwatra is an urology physician in Conroe, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kwatra performed 492,972 Medicare services across 11,159 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kwatra received a total of $9,320 from 28 pharmaceutical and/or device companies across 162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kwatra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in TX
$9,320 industry payments
Medicare Practice Summary
Medicare Utilization ↗492,972
Medicare services
Top 0% in TX for urology physician
11,159
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~25,946 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
421,305 | $0 | $0 |
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
30,552 | $34 | $88 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
7,638 | $68 | $175 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
5,097 | $34 | $44 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
5,092 | $34 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,827 | $85 | $313 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
2,548 | $34 | $88 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
2,548 | $34 | $88 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
2,548 | $34 | $100 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
2,547 | $34 | $88 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
2,547 | $34 | $88 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,643 | $61 | $213 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,468 | $7 | $55 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,370 | $10 | $73 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
824 | $0 | $2 |
| Injection, garamycin, gentamicin, up to 80 mg | 384 | $2 | $5 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
381 | $55 | $214 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
270 | $10 | $90 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
217 | $111 | $478 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
177 | $565 | $1,992 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
173 | $3 | $11 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 150 | $125 | $663 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
139 | $24 | $93 |
| Complicated change of bladder tube A complex surgical procedure to replace or modify a urinary diversion tube or conduit. This involves intricate manipulation of the urinary tract to ensure proper drainage and function. |
81 | $96 | $375 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
80 | $41 | $211 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
67 | $407 | $1,700 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
61 | $142 | $478 |
| Complicated insertion of bladder tube | 44 | $106 | $362 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
41 | $0 | $2 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
36 | $28 | $200 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
24 | $500 | $2,068 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
22 | $266 | $1,182 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
20 | $271 | $983 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
20 | $139 | $323 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $175 | $722 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
15 | $42 | $176 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,320
Total received (2018-2024)
Avg $1,331/year across 7 years
Top 21% in TX for urology physician
28
Companies
162
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,222 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$98 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$523
2023
$363
2022
$1,586
2021
$2,309
2020
$842
2019
$2,784
2018
$914
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Coloplast Corp
$3,787
Axonics, Inc.
$2,368
COLOPLAST CORP
$725
Astellas Pharma US Inc
$604
Axonics Modulation Technologies, Inc.
$321
PFIZER INC.
$280
Teleflex LLC
$138
Endo Pharmaceuticals Inc.
$133
FORTE BIO-PHARMA LLC
$125
Abbott Laboratories
$108
Boston Scientific Corporation
$101
McKesson Medical-Surgical, Inc.
$94
Antares Pharma, Inc.
$65
DENTSPLY IH Inc.
$52
PROCEPT BioRobotics Corporation
$50
Merck Sharp & Dohme LLC
$45
KARL STORZ Lithotripsy-America, Inc.
$37
Ferring Pharmaceuticals Inc.
$36
Sumitomo Pharma America, Inc.
$34
AbbVie Inc.
$32
Blue Earth Diagnostics Limited
$30
Myriad Genetic Laboratories, Inc.
$30
Mission Pharmacal Company
$28
DENTSPLY IH AB
$27
UROVANT SCIENCES INC
$22
Clarus Therapeutics Inc.
$17
BOSTON SCIENTIFIC CORPORATION
$17
Supernus Pharmaceuticals, Inc.
$14
Top 3 companies account for 73.8% of total payments
Associated products mentioned in payments ›
ALTIS · AQUABEAM SYSTEM · AVEED · Altis · Axium INS DRG IPG · Axonics · Axonics r-SNM System · Axumin · Bulkamid · FEMALE INCONTINENCE · GEMTESA · GENERAL - BPH · JATENZO · KEYTRUDA · LITHOVUE · LOFRIC · LUPRON DEPOT · LoFric · MYRBETRIQ · Myrbetriq · PENILE & TESTICULAR RECONSTRUCTN · PROLARIS · PROLATE · Porges Coloplast · REZUM · SUPERION · SpaceOAR VUE System - 10mL · TITAN · TLANDO · TOVIAZ · Titan · UROLIFT · Uribel · XIAFLEX · XTANDI · XYOSTED · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
35
Per 100K population
5.3
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kwatra is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kwatra experienced with testosterone injection?
Based on Medicare claims data, Dr. Kwatra performed 421,305 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kwatra receive payments from pharmaceutical companies?
Yes. Dr. Kwatra received a total of $9,320 from 28 companies across 162 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kwatra's costs compare to other urology physicians in Conroe?
Dr. Kwatra's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kwatra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Conroe
Browse urology physicians in Conroe ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
COLOPLAST CORP Payments to Doctors
See all physicians who received payments from COLOPLAST CORP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology